Aditxt, Inc. Acquires Proprietary Electroencephalography (EEG) Brain Monitoring Technologies and Devices, Including NeuroCap™ and NeuroEEG™ for Telehealth and Tele-neurology Applications
Acquiring Company
Aditxt
Acquired Company
BRAIN SCIENTIFIC
Description
Aditxt, Inc. has announced the acquisition of a portfolio of EEG brain monitoring technologies and devices formerly owned by Brain Scientific, Inc. This strategic acquisition will enable Aditxt to expand its subsidiary, Pearsanta, Inc.'s capabilities to encompass a broader range of innovative solutions, offering enhanced neurological diagnostics and monitoring. The acquisition involved the issuance of 6,000 shares of its newly designated Series B-1 Convertible Preferred Stock with an aggregate stated value of $6 million to the secured creditors, and 2,625 shares of its newly designated Series B-2 Convertible Preferred Stock with an aggregate stated value of $2.625 million to another secured creditor.
Quick answer
Aditxt is acquiring BRAIN SCIENTIFIC, announced January 30, 2024. Aditxt is based in Richmond, Virginia, United States.
- How much did Aditxt pay for BRAIN SCIENTIFIC?
- The deal value was not disclosed.
- What does Aditxt do?
- Aditxt is developing technologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming.
- Where are Aditxt and BRAIN SCIENTIFIC based?
- Aditxt is based in Richmond, Virginia, United States. BRAIN SCIENTIFIC is based in Sarasota, Florida, United States.
- Who are the decision-makers at Aditxt?
- Fundz holds 1 contact at Aditxt. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Commerce and Shopping and Medical Equipment Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- CardioFocus Acquires Electrophysiology Division of Galvanize Therapeutics (January 11, 2024)
- Novartis completes acquisition of IFM Due to develop first-in-class STING antagonist program targeting innate immune system (March 13, 2024)
- Branded Legacy, Inc. signs letter of intent to purchase Sycamore BioPharma, LLC, to strengthen its position in the BioTech industry (March 1, 2024)
- XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right (February 16, 2024)
- Novo Holdings to Acquire Catalent (February 5, 2024)
- Synchron Acquires Equity Stake in ACQUANDAS (February 1, 2024)
Who to call at Aditxt, and when
When Aditxt changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Aditxt raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aditxt, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aditxt. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aditxt makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired BRAIN SCIENTIFIC?
BRAIN SCIENTIFIC was acquired by Aditxt, based in Richmond. The deal was reported on January 30, 2024. Aditxt is developing technologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming. Aditxt is privately held and operates in Biotechnology.
When did Aditxt acquire BRAIN SCIENTIFIC?
Aditxt's acquisition of BRAIN SCIENTIFIC was reported on January 30, 2024. Aditxt, Inc. has announced the acquisition of a portfolio of EEG brain monitoring technologies and devices formerly owned by Brain Scientific, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does BRAIN SCIENTIFIC do?
Brain Scientific (OTCQB: BRSF) is a collective of interdisciplinary technology companies with several commercial-stage products that serve the MedTech and other billion-dollar markets led by experienced management with proven success. It is privately held, operating in Other, and is based in Sarasota.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.